ReviewEndovascular Treatment for Type B Dissection in Marfan Syndrome: Is It Worthwhile?
Section snippets
Search Strategy
A systematic search was performed using the PubMed database to identify all studies reporting the results and evaluating the outcome of endovascular treatment of descending acute and chronic thoracic aortic dissections in patients with Marfan disease. Original articles, case series, and individual reports published in English from January 2000 to November 2011 were considered, and we looked for all the studies reporting the outcome of patients who underwent endografting for descending thoracic
Endovascular Stent Grafting in MFS Due To Aortic Dissections
We ultimately identified 12 articles with 54 patients. One article was discarded from further analysis because of possible double publication [8]; also, because there was possible overlapping in the reports of some patients between two articles [4, 10], data for 4 patients were removed from one of the two publications [4] (data were available from the authors' institution). Overall, 40 of these patients were identified from articles focused on MFS, whereas data concerning 14 additional patients
Comment
The treatment of thoracic aortic disease has changed radically with the advances made in endovascular therapy since the concept of TEVAR was first described 15 years ago. Many studies have demonstrated excellent outcomes of TEVAR for the treatment of thoracoabdominal aortic aneurysm, with reduced reported perioperative morbidity and death compared with conventional open repair. More recently, similar outcomes have been demonstrated for the treatment of type B dissections, although some recent
References (23)
- et al.
Marfan's syndrome: natural history and long-term follow-up of cardiovascular involvement
J Am Coll Cardiol
(1989) - et al.
Strategies for subacute/chronic type B aortic dissection: the Investigation Of Stent Grafts in Patients with type B Aortic Dissection (INSTEAD) trial 1-year outcome
J Thorac Cardiovasc Surg
(2010) - et al.
Stent graft repair of descending aortic dissection in patients with Marfan syndrome: an effective alternative to open reoperation?
J Thorac Cardiovasc Surg
(2009) - et al.
Stent grafting of dissected descending aorta in patients with Marfan's syndrome: mid-term results
JACC Cardiovasc Interv
(2008) - et al.
Endovascular management of chronic aortic dissection in patients with Marfan syndrome
J Vasc Surg
(2009) - et al.
Endovascular treatment of acute and chronic aortic dissection: midterm results from the Talent Thoracic Retrospective Registry
J Thorac Cardiovasc Surg
(2009) - et al.
Early and midterm results of thoracic endovascular aortic repair of chronic type B aortic dissection
J Thorac Cardiovasc Surg
(2010) - et al.
Paraplegia as a symptom of failure after endovascular therapy of type B aortic dissection in Marfan syndrome
J Vasc Surg
(2009) - et al.
Proximal aortic perforation after endovascular repair of a type B dissection in a patient with Marfan syndrome
J Vasc Surg
(2009) - et al.
Endovascular treatment of complicated aortic aneurysms in patients with underlying arteriopathies
Ann Vasc Surg
(2006)
Stent graft placement of the thoracoabdominal aorta in a patient with Marfan syndrome
J Thorac Cardiovasc Surg
Cited by (63)
2022 ACC/AHA guideline for the diagnosis and management of aortic disease: A report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines
2023, Journal of Thoracic and Cardiovascular Surgery2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines
2022, Journal of the American College of CardiologyThe Society of Thoracic Surgeons/American Association for Thoracic Surgery Clinical Practice Guidelines on the Management of Type B Aortic Dissection
2022, Annals of Thoracic SurgeryCitation Excerpt :Data regarding the use of TEVAR to treat connective tissue disorder patients with TBAD are limited to data registries and small series. Pacini and colleagues139 performed a comprehensive review of 5572 studies to assess the early and late results of TEVAR in Marfan patients with acute and chronic TBAD, revealing 12 citations with data on 54 patients (11 acute and 43 chronic). The procedural incidence of mortality, stroke, and paralysis were all 1.9%.
The Society of Thoracic Surgeons/American Association for Thoracic Surgery clinical practice guidelines on the management of type B aortic dissection
2022, Journal of Thoracic and Cardiovascular Surgery
- ⁎
These authors contributed equally to this paper.